Edaravone, a novel and potent free radical scavenger, effectively prevents MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Its deuterium-labeled variant, EdaravoneD5, retains the original compound's attributes while offering isotopic labeling benefits.